Prof. Dr. Matthias Beckmann

Lehrstuhl für Geburtshilfe und Frauenheilkunde

Kolposkopie der Vulva: Wann, wie, wie oft? (2025) Behrens A, Beckmann M, Gaß P, Schulmeyer C, Seibold A, Dietl A, Stübs F Journal article Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers. (2025) Häberle L, Erber R, Gaß P, Hein A, Niklos M, Volz B, Hack C, et al. Journal article Pränatale Diagnose einer Trisomie 21: Einfluss der kinderärztlichen Beratung Schwangerer und des Kontaktes zu Familien mit einem betroffenen Kind (2025) Kondakov S, Faschingbauer F, Beckmann M, Schneider H Journal article Pathologically Tumor-free Resection Margin Distance as a Surrogate Parameter in Primary Vulvar Squamous Cell Cancer: Analysis of a Large Two-Center Patient Cohort (2025) Balog E, Stübs F, Berndt R, Dietl A, Geppert CI, Hartmann A, Thunich O, et al. Journal article Malignant upgrade in lesions of uncertain malignant potential in the breast (B3 lesions) – is open excision always necessary? (2025) Heindl F, Schiel J, Hack C, Amann N, Jud S, Preuss CI, Häberle L, et al. Journal article Correction to: Comparative assessment of breast volume using a smartphone device versus MRI (Breast Cancer, (2025), 32, 1, (166-176), 10.1007/s12282-024-01647-6) (2025) Behrens A, Hübner H, Häberle L, Stamminger M, Zint D, Heindl F, Emons J, et al. Journal article, Erratum A Digital Home-Based Health Care Center for Remote Monitoring of Side Effects During Breast Cancer Therapy: Prospective, Single-Arm, Monocentric Feasibility Study (2025) Hübner H, Wurmthaler L, Goossens C, Ernst M, Mocker A, Krückel A, Kallert M, et al. Journal article Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer (2024) Fasching P, Hu C, Hart SN, Rübner M, Polley EC, Gnanaolivu RD, Hartkopf AD, et al. Journal article Replies - Letter to the Editor - “Effect of a comprehensive lifestyle intervention program on body weight and health behavior in women with breast cancer: Results from a randomized controlled trial” (2024) Hauner D, Günther J, Schederecker F, Donik L, Meyer D, Hermsdörfer J, Friedl TW, et al. Journal article Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancer (2024) Seitz K, Goossens C, Hübner H, Gaß P, Uhrig S, Heindl F, Emons J, et al. Journal article